De-escalation of antiplatelets after percutaneous coronary intervention: a Bayesian network meta-analysis of various de-escalation strategies.
Safi U KhanMuhammad Zia KhanMuhammad Shahzeb KhanAhmed MahmoodAnkur KalraEdo KaluskiErin D MichosMohamad Adnan AlkhouliPublished in: European heart journal. Cardiovascular pharmacotherapy (2022)
Early de-escalation of DAPT (1-3 months) to monotherapy with a P2Y12 inhibitor instead of aspirin might be a safer and equally effective approach compared with 12 months of DAPT in patients with PCI and DES.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- open label
- acute coronary syndrome
- st segment elevation myocardial infarction
- acute myocardial infarction
- coronary artery disease
- st elevation myocardial infarction
- coronary artery bypass grafting
- atrial fibrillation
- clinical trial
- coronary artery bypass
- cardiovascular disease